MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jac/dkaf274

Медицинская библиотека · The Journal of antimicrobial chemotherapy · 2025

Studying intrapulmonary pharmacokinetics for tuberculosis treatment: a systematic review of methodology.

van der Feltz Isabella, Wen Haini, Aarnoutse Rob E, Magis-Escurra Cecile, Svensson Elin M, Te Brake Lindsey H M

СтатьяСистематический обзорПеревод в очереди

Аннотация

OBJECTIVES

Drug concentrations at the site of disease in pulmonary tuberculosis (TB) remain limitedly available, while adequate exposures of anti-TB drugs in the lungs are required for sterilization of lesions. Intrapulmonary concentration data could benefit TB treatment optimization. We conducted a systematic review to identify methods that can be used for sampling, quantifying, describing and predicting intrapulmonary pharmacokinetics of anti-TB drugs in humans.

METHODS

Two systematic search strategies were conducted in databases Embase and PubMed, last searched on 18 July 2024. In total, 253 studies were identified, and their applied methods were classified into three different categories: (i) sampling techniques, (ii) quantitative analysis and (iii) modelling methods. All types of pulmonary diseases were included in the search.

RESULTS

Sputum sampling was reported as sampling method in nine studies, tissue biopsy in 51, bronchoalveolar lavage in 115, bronchoscopic microsampling in eight, bronchoabsorption in one and microdialysis in 12 studies. LC-MS/MS, the gold standard for drug quantification in biological samples, was used in 67 studies. Other quantification methods included positron emission tomography, reported in 12 studies and matrix-assisted laser desorption ionization mass spectrometry on lung tissue in three studies. For prediction and description of (pre)clinical intrapulmonary concentration data, population pharmacokinetic modelling was reported in 32 studies and physiologically based pharmacokinetic modelling in 35 studies.

CONCLUSIONS

Many of the identified methods are associated with considerable limitations including invasiveness, complexity, cost and lack of standardization. Most importantly, the method of choice must provide adequate representation of site of disease pharmacokinetics. Determining the best approach for studying intrapulmonary pharmacokinetics involves careful consideration of all these factors.

Для цитирования: van der Feltz Isabella, Wen Haini, Aarnoutse Rob E, Magis-Escurra Cecile, Svensson Elin M, Te Brake Lindsey H M. Studying intrapulmonary pharmacokinetics for tuberculosis treatment: a systematic review of methodology.. The Journal of antimicrobial chemotherapy. 2025. DOI: 10.1093/jac/dkaf274.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.